349 related articles for article (PubMed ID: 2127039)
1. Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease.
Rydzewski A; Sakata K; Kobayashi A; Yamazaki N; Urano T; Takada Y; Takada A
Haemostasis; 1990; 20(5):305-12. PubMed ID: 2127039
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor activity as a possible indicator of disease activity in rest angina with angiographically insignificant coronary artery stenosis.
Sakata K; Kurata C; Kobayashi A; Rydzewski A; Yamazaki N
Thromb Res; 1991 Sep; 63(5):491-502. PubMed ID: 1755002
[TBL] [Abstract][Full Text] [Related]
3. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P
Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860
[TBL] [Abstract][Full Text] [Related]
4. [Changes in tissue plasminogen activator and plasminogen activator inhibitor during administration of nitroglycerine into internal thoracic artery in dogs with acute myocardial ischemia].
Wu X; Wang CF; Sheng J; Zhu J
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Sep; 16(9):527-9. PubMed ID: 15355613
[TBL] [Abstract][Full Text] [Related]
5. Fibrinolytic response during exercise and epinephrine infusion in the same subjects.
Chandler WL; Veith RC; Fellingham GW; Levy WC; Schwartz RS; Cerqueira MD; Kahn SE; Larson VG; Cain KC; Beard JC
J Am Coll Cardiol; 1992 Jun; 19(7):1412-20. PubMed ID: 1593033
[TBL] [Abstract][Full Text] [Related]
6. [Tissue-type plasminogen activator and its inhibitor (PAI-1) in plasma in cases of non-insulin-dependent diabetes mellitus (NIDDM)].
Jokaji H; Asakura H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Nihon Ronen Igakkai Zasshi; 1990 Nov; 27(6):699-705. PubMed ID: 2127812
[TBL] [Abstract][Full Text] [Related]
7. [Effects of guan-mai-shu on tissue-type plasminogen activator and plasminogen activator inhibitor in the plasma of patients with coronary heart disease].
Xiong XZ; Mo SS
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Dec; 13(12):727-9, 708-9. PubMed ID: 8136646
[TBL] [Abstract][Full Text] [Related]
8. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
[TBL] [Abstract][Full Text] [Related]
9. Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.
Leiper K; Croll A; Booth NA; Moore NR; Sinclair T; Bennett B
J Clin Pathol; 1994 Mar; 47(3):214-7. PubMed ID: 8163691
[TBL] [Abstract][Full Text] [Related]
10. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.
Urano T; Sakakibara K; Rydzewski A; Urano S; Takada Y; Takada A
Thromb Haemost; 1990 Feb; 63(1):82-6. PubMed ID: 2111051
[TBL] [Abstract][Full Text] [Related]
11. [Tissue plasminogen activator (T-PA) and tissue plasminogen activator inhibitor (PAI-1) in patients after head injury].
Beuth W; Kotschy M; Kasprzak HA; Rość D; Osiński P; Sniegocki M
Neurol Neurochir Pol; 1996; 30(3):427-34. PubMed ID: 8965977
[TBL] [Abstract][Full Text] [Related]
12. Time dependent release of tissue-type plasminogen activator and plasminogen activator inhibitor into the circulation of pigs during shock.
Siebeck M; Spannagl M; Hoffmann H; Schramm W; Fritz H
Blood Coagul Fibrinolysis; 1991 Jun; 2(3):459-64. PubMed ID: 1834237
[TBL] [Abstract][Full Text] [Related]
13. Plasma t-PA/PAI-1 complex and blood coagulability in patients with coronary artery disease.
Yamauchi K; Suzuki T; Furumichi T; Saito H
Jpn Heart J; 1992 May; 33(3):351-8. PubMed ID: 1522691
[TBL] [Abstract][Full Text] [Related]
14. Fluctuations of euglobulin lysis time, tissue plasminogen activator, and free and total plasminogen activator inhibitor levels in plasma in daytime.
Takada A; Takada Y; Urano T; Sakakibara K; Rydzewski A
Thromb Res; 1990 Jan; 57(1):13-20. PubMed ID: 2105539
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolysis during cardiac surgery. Release of tissue plasminogen activator in arterial and coronary sinus blood.
Valen G; Eriksson E; Risberg B; Vaage J
Eur J Cardiothorac Surg; 1994; 8(6):324-30. PubMed ID: 8086178
[TBL] [Abstract][Full Text] [Related]
16. Measurements of the concentration of free plasminogen activator inhibitor (PAI-1) and its complex with tissue plasminogen activator in human plasma.
Takada Y; Takada A
Thromb Res Suppl; 1988; 8():15-22. PubMed ID: 3144765
[TBL] [Abstract][Full Text] [Related]
17. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
Soeki T; Tamura Y; Fukuda N; Ito S
Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
[TBL] [Abstract][Full Text] [Related]
18. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
19. Impaired fibrinolysis in coronary artery disease.
Francis RB; Kawanishi D; Baruch T; Mahrer P; Rahimtoola S; Feinstein DI
Am Heart J; 1988 Apr; 115(4):776-80. PubMed ID: 3128096
[TBL] [Abstract][Full Text] [Related]
20. Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration.
Lucore CL; Fujii S; Sobel BE
Circulation; 1989 Jun; 79(6):1204-13. PubMed ID: 2498004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
